The timing of the launch of any vaccine has become politically important, as U. S. President Donald Trump seeks re-election in November after making a significant investment of federal resources in vaccine development.
“For the purpose of making initial plans, the CDC has provided states with some plan assumptions as they paint specific state plans for vaccine distribution, adding in all likelihood to have limited amounts of vaccines in October and November,” a CDC spokeswoman said. Reuters.
The New York Times had reported in the past that the CDC had contacted officials from all 50 states and five major cities with the documents.
The country’s leading infectious disease specialist, Anthony Fauci, said Wednesday at MSNBC that, based on the rate of patient registration in ongoing trials of the COVID-19 vaccine, there may be sufficient clinical knowledge to know until November or December that a vaccine is effective. . .
Documents published online through the New York Times showed that the CDC is preparing for one or two COVID-19 vaccines to be available in limited doses by the end of October.
Vaccines may first be reduced to high-risk groups, adding fitness professionals, national security personnel, citizens and staff from Covid-19 long-term care facilities, the firm said in the documents.
Drug expanders, in addition to Moderna Inc, AstraZeneca Plc and Pfizer Inc, 100 are leading the race to expand an effective vaccine against respiratory diseases.
The documents describe two candidate vaccines to be maintained at temperatures of -70 and -20 degrees Celsius. These garage needs correspond to the profiles of Pfizer and Moderna candidates.
(REUTERS)